Venture Life Group (LON:VLG) Releases Earnings Results

Venture Life Group (LON:VLG) announced its quarterly earnings data on Tuesday. The company reported GBX 4.10 earnings per share for the quarter, Digital Look Earnings reports. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.

Venture Life Group Price Performance

Venture Life Group stock traded down GBX 3.20 during midday trading on Tuesday, hitting GBX 65. The company’s stock had a trading volume of 917,313 shares, compared to its average volume of 272,819. Venture Life Group has a 12 month low of GBX 52 and a 12 month high of GBX 72. The company has a quick ratio of 1.48, a current ratio of 4.71 and a debt-to-equity ratio of 0.82. The company has a market capitalization of £78.03 million, a PE ratio of 14.87, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23. The stock’s 50-day moving average price is GBX 67.59 and its 200-day moving average price is GBX 65.13.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.